世界の抗肥満薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Anti-obesity Medicine Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0405
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、抗肥満薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（処方薬、OTC薬）、用途別市場規模（男性、女性）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・抗肥満薬の市場動向
・企業の競争状況、市場シェア
・抗肥満薬の種類別市場規模（処方薬、OTC薬）
・抗肥満薬の用途別市場規模（男性、女性）
・抗肥満薬の北米市場規模2016-2027（アメリカ、カナダ）
・抗肥満薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・抗肥満薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・抗肥満薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・抗肥満薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Alizyme、Amylin Pharmaceuticals、Arena Pharmaceuticals、Boehringer Ingelheim、Eisai、GlaxoSmithKline、Orexigen Therapeutics、Vivus、Pfizer、Roche、Merck、Novo Nordisk）
・結論

Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight.

Market Analysis and Insights: Global Anti-obesity Medicine Market
The global Anti-obesity Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-obesity Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-obesity Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-obesity Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-obesity Medicine market.

Global Anti-obesity Medicine Scope and Market Size
Anti-obesity Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-obesity Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prescription Drugs
OTC Drugs

Segment by Application
Men
Women

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alizyme
Amylin Pharmaceuticals
Arena Pharmaceuticals
Boehringer Ingelheim
Eisai
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Pfizer
Roche
Merck
Novo Nordisk

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-obesity Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Anti-obesity Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti-obesity Medicine Market Perspective (2016-2027)
2.2 Anti-obesity Medicine Growth Trends by Regions
2.2.1 Anti-obesity Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-obesity Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Anti-obesity Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Anti-obesity Medicine Industry Dynamic
2.3.1 Anti-obesity Medicine Market Trends
2.3.2 Anti-obesity Medicine Market Drivers
2.3.3 Anti-obesity Medicine Market Challenges
2.3.4 Anti-obesity Medicine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti-obesity Medicine Players by Revenue
3.1.1 Global Top Anti-obesity Medicine Players by Revenue (2016-2021)
3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Anti-obesity Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-obesity Medicine Revenue
3.4 Global Anti-obesity Medicine Market Concentration Ratio
3.4.1 Global Anti-obesity Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-obesity Medicine Revenue in 2020
3.5 Anti-obesity Medicine Key Players Head office and Area Served
3.6 Key Players Anti-obesity Medicine Product Solution and Service
3.7 Date of Enter into Anti-obesity Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-obesity Medicine Breakdown Data by Type
4.1 Global Anti-obesity Medicine Historic Market Size by Type (2016-2021)
4.2 Global Anti-obesity Medicine Forecasted Market Size by Type (2022-2027)

5 Anti-obesity Medicine Breakdown Data by Application
5.1 Global Anti-obesity Medicine Historic Market Size by Application (2016-2021)
5.2 Global Anti-obesity Medicine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti-obesity Medicine Market Size (2016-2027)
6.2 North America Anti-obesity Medicine Market Size by Type
6.2.1 North America Anti-obesity Medicine Market Size by Type (2016-2021)
6.2.2 North America Anti-obesity Medicine Market Size by Type (2022-2027)
6.2.3 North America Anti-obesity Medicine Market Size by Type (2016-2027)
6.3 North America Anti-obesity Medicine Market Size by Application
6.3.1 North America Anti-obesity Medicine Market Size by Application (2016-2021)
6.3.2 North America Anti-obesity Medicine Market Size by Application (2022-2027)
6.3.3 North America Anti-obesity Medicine Market Size by Application (2016-2027)
6.4 North America Anti-obesity Medicine Market Size by Country
6.4.1 North America Anti-obesity Medicine Market Size by Country (2016-2021)
6.4.2 North America Anti-obesity Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anti-obesity Medicine Market Size (2016-2027)
7.2 Europe Anti-obesity Medicine Market Size by Type
7.2.1 Europe Anti-obesity Medicine Market Size by Type (2016-2021)
7.2.2 Europe Anti-obesity Medicine Market Size by Type (2022-2027)
7.2.3 Europe Anti-obesity Medicine Market Size by Type (2016-2027)
7.3 Europe Anti-obesity Medicine Market Size by Application
7.3.1 Europe Anti-obesity Medicine Market Size by Application (2016-2021)
7.3.2 Europe Anti-obesity Medicine Market Size by Application (2022-2027)
7.3.3 Europe Anti-obesity Medicine Market Size by Application (2016-2027)
7.4 Europe Anti-obesity Medicine Market Size by Country
7.4.1 Europe Anti-obesity Medicine Market Size by Country (2016-2021)
7.4.2 Europe Anti-obesity Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti-obesity Medicine Market Size (2016-2027)
8.2 Asia-Pacific Anti-obesity Medicine Market Size by Type
8.2.1 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-obesity Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-obesity Medicine Market Size by Application
8.3.1 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-obesity Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-obesity Medicine Market Size by Region
8.4.1 Asia-Pacific Anti-obesity Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-obesity Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti-obesity Medicine Market Size (2016-2027)
9.2 Latin America Anti-obesity Medicine Market Size by Type
9.2.1 Latin America Anti-obesity Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Anti-obesity Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Anti-obesity Medicine Market Size by Type (2016-2027)
9.3 Latin America Anti-obesity Medicine Market Size by Application
9.3.1 Latin America Anti-obesity Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Anti-obesity Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Anti-obesity Medicine Market Size by Application (2016-2027)
9.4 Latin America Anti-obesity Medicine Market Size by Country
9.4.1 Latin America Anti-obesity Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Anti-obesity Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti-obesity Medicine Market Size (2016-2027)
10.2 Middle East & Africa Anti-obesity Medicine Market Size by Type
10.2.1 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-obesity Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-obesity Medicine Market Size by Application
10.3.1 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-obesity Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-obesity Medicine Market Size by Country
10.4.1 Middle East & Africa Anti-obesity Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-obesity Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alizyme
11.1.1 Alizyme Company Details
11.1.2 Alizyme Business Overview
11.1.3 Alizyme Anti-obesity Medicine Introduction
11.1.4 Alizyme Revenue in Anti-obesity Medicine Business (2016-2021)
11.1.5 Alizyme Recent Development
11.2 Amylin Pharmaceuticals
11.2.1 Amylin Pharmaceuticals Company Details
11.2.2 Amylin Pharmaceuticals Business Overview
11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Introduction
11.2.4 Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
11.2.5 Amylin Pharmaceuticals Recent Development
11.3 Arena Pharmaceuticals
11.3.1 Arena Pharmaceuticals Company Details
11.3.2 Arena Pharmaceuticals Business Overview
11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Introduction
11.3.4 Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
11.3.5 Arena Pharmaceuticals Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Anti-obesity Medicine Introduction
11.4.4 Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai Anti-obesity Medicine Introduction
11.5.4 Eisai Revenue in Anti-obesity Medicine Business (2016-2021)
11.5.5 Eisai Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Anti-obesity Medicine Introduction
11.6.4 GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Orexigen Therapeutics
11.7.1 Orexigen Therapeutics Company Details
11.7.2 Orexigen Therapeutics Business Overview
11.7.3 Orexigen Therapeutics Anti-obesity Medicine Introduction
11.7.4 Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2016-2021)
11.7.5 Orexigen Therapeutics Recent Development
11.8 Vivus
11.8.1 Vivus Company Details
11.8.2 Vivus Business Overview
11.8.3 Vivus Anti-obesity Medicine Introduction
11.8.4 Vivus Revenue in Anti-obesity Medicine Business (2016-2021)
11.8.5 Vivus Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Anti-obesity Medicine Introduction
11.9.4 Pfizer Revenue in Anti-obesity Medicine Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Anti-obesity Medicine Introduction
11.10.4 Roche Revenue in Anti-obesity Medicine Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Anti-obesity Medicine Introduction
11.11.4 Merck Revenue in Anti-obesity Medicine Business (2016-2021)
11.11.5 Merck Recent Development
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Details
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Anti-obesity Medicine Introduction
11.12.4 Novo Nordisk Revenue in Anti-obesity Medicine Business (2016-2021)
11.12.5 Novo Nordisk Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anti-obesity Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Drugs
Table 3. Key Players of OTC Drugs
Table 4. Global Anti-obesity Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anti-obesity Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-obesity Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Anti-obesity Medicine Market Share by Regions (2016-2021)
Table 8. Global Anti-obesity Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Anti-obesity Medicine Market Share by Regions (2022-2027)
Table 10. Anti-obesity Medicine Market Trends
Table 11. Anti-obesity Medicine Market Drivers
Table 12. Anti-obesity Medicine Market Challenges
Table 13. Anti-obesity Medicine Market Restraints
Table 14. Global Anti-obesity Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Anti-obesity Medicine Market Share by Players (2016-2021)
Table 16. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Medicine as of 2020)
Table 17. Ranking of Global Top Anti-obesity Medicine Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Anti-obesity Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-obesity Medicine Product Solution and Service
Table 21. Date of Enter into Anti-obesity Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Anti-obesity Medicine Revenue Market Share by Type (2016-2021)
Table 25. Global Anti-obesity Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Anti-obesity Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Anti-obesity Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Anti-obesity Medicine Revenue Market Share by Application (2016-2021)
Table 29. Global Anti-obesity Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Anti-obesity Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti-obesity Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Anti-obesity Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 61. Alizyme Company Details
Table 62. Alizyme Business Overview
Table 63. Alizyme Anti-obesity Medicine Product
Table 64. Alizyme Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 65. Alizyme Recent Development
Table 66. Amylin Pharmaceuticals Company Details
Table 67. Amylin Pharmaceuticals Business Overview
Table 68. Amylin Pharmaceuticals Anti-obesity Medicine Product
Table 69. Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 70. Amylin Pharmaceuticals Recent Development
Table 71. Arena Pharmaceuticals Company Details
Table 72. Arena Pharmaceuticals Business Overview
Table 73. Arena Pharmaceuticals Anti-obesity Medicine Product
Table 74. Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 75. Arena Pharmaceuticals Recent Development
Table 76. Boehringer Ingelheim Company Details
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim Anti-obesity Medicine Product
Table 79. Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 80. Boehringer Ingelheim Recent Development
Table 81. Eisai Company Details
Table 82. Eisai Business Overview
Table 83. Eisai Anti-obesity Medicine Product
Table 84. Eisai Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 85. Eisai Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Anti-obesity Medicine Product
Table 89. GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Orexigen Therapeutics Company Details
Table 92. Orexigen Therapeutics Business Overview
Table 93. Orexigen Therapeutics Anti-obesity Medicine Product
Table 94. Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 95. Orexigen Therapeutics Recent Development
Table 96. Vivus Company Details
Table 97. Vivus Business Overview
Table 98. Vivus Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 99. Vivus Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Anti-obesity Medicine Product
Table 103. Pfizer Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 104. Pfizer Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Anti-obesity Medicine Product
Table 108. Roche Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 109. Roche Recent Development
Table 110. Merck Company Details
Table 111. Merck Business Overview
Table 112. Merck Anti-obesity Medicine Product
Table 113. Merck Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 114. Merck Recent Development
Table 115. Novo Nordisk Company Details
Table 116. Novo Nordisk Business Overview
Table 117. Novo Nordisk Anti-obesity Medicine Product
Table 118. Novo Nordisk Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 119. Novo Nordisk Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-obesity Medicine Market Share by Type: 2020 VS 2027
Figure 2. Prescription Drugs Features
Figure 3. OTC Drugs Features
Figure 4. Global Anti-obesity Medicine Market Share by Application: 2020 VS 2027
Figure 5. Men Case Studies
Figure 6. Women Case Studies
Figure 7. Anti-obesity Medicine Report Years Considered
Figure 8. Global Anti-obesity Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Anti-obesity Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti-obesity Medicine Market Share by Regions: 2020 VS 2027
Figure 11. Global Anti-obesity Medicine Market Share by Regions (2022-2027)
Figure 12. Global Anti-obesity Medicine Market Share by Players in 2020
Figure 13. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Medicine as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Anti-obesity Medicine Revenue in 2020
Figure 15. Global Anti-obesity Medicine Revenue Market Share by Type (2016-2021)
Figure 16. Global Anti-obesity Medicine Revenue Market Share by Type (2022-2027)
Figure 17. North America Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 19. North America Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 20. North America Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 21. United States Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 25. Europe Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 26. Europe Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 27. Germany Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Anti-obesity Medicine Market Share by Region (2016-2027)
Figure 37. China Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 45. Latin America Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 46. Latin America Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 47. Mexico Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 53. Turkey Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Alizyme Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 57. Amylin Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 58. Arena Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 60. Eisai Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 62. Orexigen Therapeutics Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 63. Vivus Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 67. Novo Nordisk Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の止瀉薬市場規模・現状・予測（2021年-2027年）

Global Anti-diarrheal Medicine Market Size, Status and Forecast 2021-2027
QYR2104Z0382 2021年4月 85Pages
QYResearch社発行の本調査資料では、止瀉薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ロペラミド、次サリチル酸ビスマス、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の肥満管理市場規模・現状・予測（2021年-2027年）

Global Obesity Management Market Size, Status and Forecast 2021-2027
QYR2104Z4214 2021年4月 97Pages
QYResearch社発行の本調査資料では、肥満管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、専門クリニック、外来手術センター、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の抗肥満薬市場 2021：企業別、地域別、種類・用途別

Global Anti-Obesity Drugs (Anti-obesity Medication) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z01001 2021年4月 139Pages
当調査資料では、抗肥満薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗肥満薬の種類別市場規模（処方薬、OTC薬）、用途別市場規模（小児期（0-6）、少年（7-17）、青年（18-40）、中年（41-60）、高齢者（60歳以上））、地域別市場規模（北...

世界の抗肥満処方薬市場 2021：企業別、地域別、種類・用途別

Global Anti-Obesity Prescription Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z01002 2021年4月 105Pages
当調査資料では、抗肥満処方薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗肥満処方薬の種類別市場規模（小児、成人）、用途別市場規模（病院薬局、小売薬局、Eコマース）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、...

世界の肥満介入装置市場規模・現状・予測（2021年-2027年）

Global Obesity Intervention Devices Market Size, Status and Forecast 2021-2027
QYR2104Z4213 2021年4月 98Pages
QYResearch社発行の本調査資料では、肥満介入装置のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胃バンド、電気刺激システム、胃バルーンシステム、胃排出システム、食欲抑制剤）、用途別市場規模（病院、消化器クリニック、外来手術センター）、主...

世界の肥満治療市場規模・現状・予測（2021年-2027年）

Global Obesity Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4215 2021年4月 132Pages
QYResearch社発行の本調査資料では、肥満治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術＆インプラント装置、薬物療法、食事療法、その他）、用途別市場規模（子供、大人）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のデジタル医療市場規模・現状・予測（2021年-2027年）

Global Digital Medicine Market Size, Status and Forecast 2021-2027
QYR2104Z1877 2021年4月 94Pages
QYResearch社発行の本調査資料では、デジタル医療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モバイルヘルス、EMR/EHR、テレヘルス、ワイヤレスヘルス）、用途別市場規模（糖尿病、メンタルヘルス、心臓病、喫煙、服薬不順守、肥満、CO...

抗肥満薬の世界市場2020年：分析と予測（～2025年）

Anti-obesity Drug Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Product Type
MR2104PF590 2021年4月 80Pages
Prof Research社の本調査レポートでは、抗肥満薬の世界市場について調査・分析し、抗肥満薬のグローバル市場概要、市場動向、産業構造、貿易動向（輸出・輸入）、地域別市場規模（北米、南米、アジア、ヨーロッパ、中東・アフリカ）、世界の市場規模予測、セグメント別分析（種類別（オルリスタット、ナルトレ...

世界の抗ニキビ薬市場規模・現状・予測（2021年-2027年）

Global Anti Ance Drug Market Size, Status and Forecast 2021-2027
QYR2104Z0361 2021年4月 99Pages
QYResearch社発行の本調査資料では、抗ニキビ薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、処方薬）、用途別市場規模（局所、経口）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、...

世界のスポーツ医療市場規模・現状・予測（2021年-2027年）

Global Sports Medicine Market Size, Status and Forecast 2021-2027
QYR2104Z5414 2021年4月 96Pages
QYResearch社発行の本調査資料では、スポーツ医療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（再建製品、サポート、回復製品、付属品）、用途別市場規模（膝、肩、腰、背骨）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の抗肥満処方薬市場 2021：企業別、地域別、種類・用途別 The Anti-Obesity Prescription Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
世界の抗肥満薬市場 2021：企業別、地域別、種類・用途別 The Anti-Obesity Drugs (Anti-obesity Medication) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
世界の止瀉薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-diarrheal Medicine Market The global Anti-diarrheal Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…
抗肥満薬の世界市場2020年：分析と予測（～2025年） This report describes the global market size of Anti-obesity Drug from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 2015 to 202…
世界の肥満管理市場規模・現状・予測（2021年-2027年） Lifestyle diseases such as diabetes and other chronic ailments are the main cause of obesity around the world. Improved healthcare and medical facilities have led to an increase in the life expectancy of people, which is the primary reason for the large geriatric population seen in the developed wor…